Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2113805

Astellas Pharma Inc. - Strategy and SWOT Report

Description:
Astellas Pharma Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
- Intelligence on Astellas Pharma Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Astellas Pharma (Astellas or 'the company') is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company operates in Japan, Asia, the Americas, Europe, Middle East, and Africa (EMEA) and Oceania. It is headquartered in Tokyo, Japan and employed 17,649 people as of March 31, 2014. The company recorded revenues of JPY1,139,909 million (approximately $11,399.1 million) during the financial year ended March 2014 (FY2014), an increase of 16.1% over FY2013. The operating profit of the company was JPY116,806 million (approximately $1,168.1 million) in FY2014, a decrease of 3.9% compared with FY2013. The net profit of the company was JPY90,874 million (approximately $908.7 million) in FY2014, a decrease of 1.7% compared with FY2013.

Reasons to Purchase:

- Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Astellas Pharma Inc.’s business structure, strategy and prospects
 
Contents:
Company Snapshot

Astellas Pharma Inc.: Company Overview

Astellas Pharma Inc.: Overview and Key Facts

- Astellas Pharma Inc.: Overview

- Astellas Pharma Inc.: Key Facts

Astellas Pharma Inc.: Key Employees

Astellas Pharma Inc.: Key Employee Biographies

Astellas Pharma Inc.: Major Products and Services

Astellas Pharma Inc.: Company History

Astellas Pharma Inc.: Management Statement

Astellas Pharma Inc.: Locations and Subsidiaries

Astellas Pharma Inc.: Key Competitors

Astellas Pharma Inc.: Company Analysis

Astellas Pharma Inc.: Business Description

Astellas Pharma Inc.: SWOT Analysis

- Astellas Pharma Inc.: SWOT Overview

- Astellas Pharma Inc.: Strengths

- Astellas Pharma Inc.: Weaknesses

- Astellas Pharma Inc.: Opportunities

- Astellas Pharma Inc.: Threats

Astellas Pharma Inc.: Corporate Financial Deals Activity

Astellas Pharma Inc.: Financial Deals Overview

Astellas Pharma Inc.: Targets and Partners

Astellas Pharma Inc.: Top Deals 2011 - 2015YTD-

Astellas Pharma Inc.: Advisors

- Astellas Pharma Inc.: Top Legal Advisors

Astellas Pharma Inc.: Mergers and Acquisitions

Astellas Pharma Inc.: Corporate Venturing

Astellas Pharma Inc.: Partnership

Astellas Pharma Inc.: Divestments

Astellas Pharma Inc.: Recent Developments

Astellas Pharma Inc.: News and Events Summary

Astellas Pharma Inc.: Business Expansion

Astellas Pharma Inc.: Contracts

Astellas Pharma Inc.: Corporate Governance

Astellas Pharma Inc.: Regulatory and Legal Events

Astellas Pharma Inc.: Research & Development

Appendix

Contact Us

Methodology

Definitions

About

List of Tables:

Table 1: Astellas Pharma Inc.: Key Facts

Table 2: Astellas Pharma Inc.: Key Employees

Table 4: Astellas Pharma Inc.: Key Competitors

Table 5: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM-)

Table 6: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2011 - YTD-2015)

Table 7: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)

Table 8: Astellas Pharma Inc.: Targets and Partners

Table 9: Astellas Pharma Inc.: Top Deals 2011 - 2015YTD-

Table 10: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)

Table 11: Astellas Pharma Inc.: M&A Volume and Value Trend (2011 - YTD-2015)

Table 12: Astellas Pharma Inc.: M&A Activity by Geography (2011 - YTD-2015)

Table 13: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD-2015)

Table 14: Astellas Pharma Inc.: Corporate Venturing by Geography (2011 - YTD-2015)

Table 15: Astellas Pharma Inc.: Partnership Volume and Value Trend (2011 - YTD-2015)

Table 16: Astellas Pharma Inc.: Partnership Trend by Deal Type (2011 - YTD-2015)

Table 17: Astellas Pharma Inc.: Divestments Volume and Value Trend (2011 - YTD-2015)

Table 18: Astellas Pharma Inc.: Divestments by Geography (2011 - YTD-2015)

Table 19: Astellas Pharma Inc.: News and Events Summary

Table 20: Astellas Pharma Inc.: Business Expansion

Table 21: Astellas Pharma Inc.: Contracts

Table 22: Astellas Pharma Inc.: Corporate Governance

Table 23: Astellas Pharma Inc.: Regulatory and Legal Events

Table 24: Astellas Pharma Inc.: Research & Development

List of Figures:

Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM-)

Figure 2: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2011 - YTD-2015)

Figure 3: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)

Figure 4: Astellas Pharma Inc.: M&A Volume and Value Trend (2011 - YTD-2015)

Figure 5: Astellas Pharma Inc.: M&A Activity by Geography (2011 - YTD-2015)

Figure 6: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD-2015)

Figure 7: Astellas Pharma Inc.: Corporate Venturing by Geography (2011 - YTD-2015)

Figure 8: Astellas Pharma Inc.: Partnership Volume and Value Trend (2011 - YTD-2015)

Figure 9: Astellas Pharma Inc.: Partnership Trend by Deal Type (2011 - YTD-2015)

Figure 10: Astellas Pharma Inc.: Divestments Volume and Value Trend (2011 - YTD-2015)

Figure 11: Astellas Pharma Inc.: Divestments by Geography (2011 - YTD-2015)
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2113805

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Jul 5, 2015
11:00:46 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Astellas Pharma Inc. - Strategy and SWOT Report

Web Address

http://www.researchandmarkets.com/reports/2113805

Office Code

SC

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 175
Electronic (PDF) - Enterprisewide USD 438

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Jul 5, 2015
11:00:46 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

You will receive an email with a link to a secure page to enter your credit card details.

 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)